Hormone therapy may boost weight loss for postmenopausal women on semaglutide
Postmenopausal women on hormone therapy had higher total body weight loss with semaglutide for up to 12 months vs. no hormone therapy.
Healthcare News
Bariatric surgery linked to heart health improvements in people with severe obesity
Bariatric surgery may result in significant cardiometabolic improvements, particularly among younger, female, or white people and those without comorbidities, according to new research, titled "Cardiometabolic Improvements After Metabolic Surgery and Related Pre-surgery Factors," published in the Journal of the Endocrine Society.
New weight loss pill more effective than Ozempic: Novo Nordisk
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring.
Replacing sugar with sweeteners can improve weight loss control over the long term in overweight adults
New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), suggests that replacing sugar-sweetened food and drinks with low/no energy sweetened products can help weight control for at least one year after rapid weight loss in adults, without increasing the risk of type 2 diabetes or cardiovascular disease.
Only one in five state Medicaid programs covers weight loss medications: Study
Newer medications are remarkably effective, but they are quite expensive, which is a major concern for states when deciding whether to cover these drugs.
